Search

Search Results
Results 1 - 10 of 1250 for Medical diagnostics
  • Supplier Profile
    The National University of Singapore (NUS) acknowledges the global trend that nanotechnology is expected to be a key technology. NUS, in tradition of spearheading cutting-edge research programs, has...
  • Supplier Profile
    Strem Chemicals, Inc. established in 1964, is a privately–held company that manufactures and markets specialty chemicals of high purity. Its clients include academic, industrial and government...
  • Supplier Profile
    CPI is the driving force behind a number of the North East's strategic R&D initiatives. Each of CPI' programmes focuses on bringing cutting edge technology research to the region, which...
  • Supplier Profile
    Nanogen’s advanced technologies provide researchers, clinicians and physicians worldwide with improved methods and tools to predict, diagnose, and ultimately help treat disease. The company's...
  • Supplier Profile
    The Georgia Institute of Technology is one of the nation's top research universities, distinguished by its commitment to improving the human condition through advanced science and technology. Georgia...
  • Article - 6 Apr 2005
    A research team has found that certain types of iron nanoparticles could be useful in cleaning up carbon tetrachloride contamination in groundwater, via the degradation process. The findings of this...
  • Supplier Profile
    Created in 1964, Inserm is a public institution with a scientific and technical vocation, under the dual auspices of the Ministry of Health and the Ministry of Research. Inserm is the only French...
  • Article - 1 Aug 2005
    This article discusses how nanomaterials and nanoparticles are increasingly being used in the medical and pharmaceutical sectors.
  • Article - 12 Apr 2005
    Advances in medical nanotechnology are likely to be used in biomedical applications for space projects. This article looks at medical diagnostics, biochips, lab on a chip systems, medical sensors,...
  • Supplier Profile
    Invitrogen Corporation (NASDAQ: IVGN) is a global company with revenues of $1.2 billion. We provide products and services to pharmaceutical and biotechnology companies, as well as academic and...